Richard Francis is global head of Sandoz, the generic drugs division of Novartis. He is a member of the Swiss pharmaceutical company's executive committee. He joined Sandoz after a 13-year career in U.S. biotechnology firm Biogen Idec, where he led the development of several drugs to treat multiple sclerosis. Prior to that, Francis worked for Sanofi in the United Kingdom.
On World Pneumonia Day, it's time to turn our attention to making sure that the children most at risk of death from the disease actually receive the appropriate interventions. An exclusive commentary by Richard Francis, head of Sandoz, the generic drugs division of Swiss pharmaceutical giant Novartis.